Many products in ForaCare’s blood glucose and blood pressure monitoring systems are clinically validated. Below is a summary of all current and relevant validations. A symbol placed next to the product indicates the validation protocol and the researcher who participated in the study.
FORA strives for continued excellence in clinical competency and our priority is to ensure our blood glucose monitoring systems meet the emerging requirements for higher accuracy in blood glucose measurement including the new ISO criteria of ± 15%.
A printable version of the validation overview of each clinical validation conducted is also available.
|Blood Glucose Monitoring System||Number of Validations|
|FORA Diamond PRIMA (DM10)||4|
|FORA Diamond VOICE (DM20)||1|
|FORA Diamond MINI (DM30)||6|
|FORA ADVANCED pro GD40g||1|
|FORA COMFORT pro GD40||8|
|FORA COMFORT basic G20||5|
|FORA COMFORT plus G30||1|
|FORA COMFORT advance G31||2|
|FORA COMFORT voice V30||3|
|Number of Validations||Blood Glucose / Blood Pressure 2-in-1
|ESH 2002||ESH 2010||Dabl|
|1||FORA P30 Plus||PASS||Recommended|
|1||FORA Diamond CUFF BP||PASS||Recommended|
Clinically proven to meet the requirement of 15% at glucose levels of 100mg/dL (5.5 mmol/L) or above.
Clinically validated at ForaCare facilities, according to current ISO guidelines and requirements.
Clinically validated by the Agence nationale de sécurité du médicament et des produits de santé (ANSM)
Clinically validated at the Institute for Diabetes-Technology, University of Ulm, Germany
Clinically validated according to the guidelines and requirements set forth by TNO.
Clinically validated by Professor Nilsson from the Malmö University of Sweden